Lapatinib 250 Mg

Lapatinib, used in the form of lapatinib ditosylate is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor pathways